Insiders · Profile

VIKING GLOBAL PERFORMANCE LLC

10% owner at Roivant Sciences · 10% owner at Adaptive Biotechnologies · 10% owner at BridgeBio Pharma · and 2 more. Filing since 2 Oct 2014. CIK 0001132625

Company
Date
Role
Action
Shares
Amount
Of holding
22 Jun 2023
10% owner
Sold at will
13,000,000
$128.70M
95.3%
11 Nov 2020
10% owner
Sold, plan not stated
2,500,000
$123.79M
7.5%
28 Jan 2020
10% owner
Sold, plan not stated
4,912,899
$122.71M
12.8%
1 Jul 2019
10% owner
Bought
250,000
$5.00M
17.5%
27 Jun 2019
10% owner
Bought
4,705,900
$80.00M
21.5%
8 Feb 2015
10% owner
Bought
1,020,407
no price
59.7%
8 Feb 2015
10% owner
Bought
1,020,407
no price
opened
2 Oct 2014
10% owner
Bought
479,250
no price
37.7%
2 Oct 2014
10% owner
Bought
373,789
no price
40.4%
9 decisions on file.